Does FLUVASTATIN Cause Hyperparathyroidism secondary? 26 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 26 reports of Hyperparathyroidism secondary have been filed in association with FLUVASTATIN (FLUVASTATIN SODIUM ER). This represents 1.4% of all adverse event reports for FLUVASTATIN.
26
Reports of Hyperparathyroidism secondary with FLUVASTATIN
1.4%
of all FLUVASTATIN reports
0
Deaths
26
Hospitalizations
How Dangerous Is Hyperparathyroidism secondary From FLUVASTATIN?
Of the 26 reports, 26 (100.0%) required hospitalization.
Is Hyperparathyroidism secondary Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for FLUVASTATIN. However, 26 reports have been filed with the FAERS database.
What Other Side Effects Does FLUVASTATIN Cause?
Myalgia (577)
Dizziness (304)
Arthralgia (263)
Diarrhoea (260)
Headache (260)
Pruritus (257)
Dyspnoea (234)
Fall (234)
Insomnia (234)
Fatigue (231)
What Other Drugs Cause Hyperparathyroidism secondary?
ESOMEPRAZOLE (1,357)
OMEPRAZOLE (1,274)
PANTOPRAZOLE (947)
LANSOPRAZOLE (888)
DEXLANSOPRAZOLE (382)
RABEPRAZOLE (108)
DENOSUMAB (60)
FUROSEMIDE (49)
OMEPRAZOLE\SODIUM BICARBONATE (48)
ESOMEPRAZOLE\NAPROXEN (47)
Which FLUVASTATIN Alternatives Have Lower Hyperparathyroidism secondary Risk?
FLUVASTATIN vs FLUVOXAMINE
FLUVASTATIN vs FOLATE
FLUVASTATIN vs FOLIC ACID
FLUVASTATIN vs FOLINIC ACID
FLUVASTATIN vs FOLLICLE STIMULATING HORMONE BETA POLYPEPTIDE\LUTROPIN ALFA